Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Suman Tomar, Rakesh Kumar Yadav, Kamal Shah & Hitesh Kumar Dewangan. (2024) A comprehensive review on carrier mediated nose to brain targeting: emphasis on molecular targets, current trends, future prospects, and challenges. International Journal of Polymeric Materials and Polymeric Biomaterials 73:2, pages 91-103.
Read now
Read now
Amrish Kumar, Aditya Nath Pandey & Sunil Kumar Jain. (2016) Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Delivery 23:3, pages 671-683.
Read now
Read now
Tarun Garg, Saurav Bhandari, Goutam Rath & Amit K. Goyal. (2015) Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. Journal of Drug Targeting 23:10, pages 865-887.
Read now
Read now
Sumeet Sood, Kunal Jain & K. Gowthamarajan. (2014) Intranasal therapeutic strategies for management of Alzheimer’s disease. Journal of Drug Targeting 22:4, pages 279-294.
Read now
Read now
Articles from other publishers (11)
Radka Boyuklieva & Bissera Pilicheva. (2022) Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. Biomedicines 10:7, pages 1706.
Crossref
Crossref
Ying Qu, Ang Li, Long Ma, Sajid Iqbal, Xiao Sun, Wenqing Ma, Chunyan Li, Dandan Zheng, Zixuan Xu, Zhongxi Zhao & Dedong Ma. (2021) Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy. International Journal of Pharmaceutics 597, pages 120250.
Crossref
Crossref
Shiv Bahadur & Kamla Pathak. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
187
207
.
Maria Cristina Bonferoni, Giovanna Rassu, Elisabetta Gavini, Milena Sorrenti, Laura Catenacci & Paolo Giunchedi. (2020) Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases. Pharmaceutics 12:12, pages 1246.
Crossref
Crossref
Xinxin Wang & Fangxia Guan. 2019. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders. Therapeutic Intranasal Delivery for Stroke and Neurological Disorders
117
133
.
Abdur Rauf Khan, Mengrui Liu, Muhammad Wasim Khan & Guangxi Zhai. (2017) Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, pages 364-389.
Crossref
Crossref
Aroonsri Priprem, Jeffrey R Johns, Sucharat Limsitthichaikoon, Wanwisa Limphirat, Pramote Mahakunakorn & Nutjaree Prateepawanit Johns. (2017) Intranasal melatonin nanoniosomes: pharmacokinetic, pharmacodynamics and toxicity studies. Therapeutic Delivery 8:6, pages 373-390.
Crossref
Crossref
Deepak Sharma, Rakesh Kumar Sharma, Navneet Sharma, Reema Gabrani, Sanjeev K. Sharma, Javed Ali & Shweta Dang. (2015) Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles. AAPS PharmSciTech 16:5, pages 1108-1121.
Crossref
Crossref
Russel J. Reiter, Dun Xian Tan, Seok Joong Kim & Maria Helena C. Cruz. (2014) Delivery of pineal melatonin to the brain and SCN: role of canaliculi, cerebrospinal fluid, tanycytes and Virchow–Robin perivascular spaces. Brain Structure and Function 219:6, pages 1873-1887.
Crossref
Crossref
Matthias van Woensel, Nathalie Wauthoz, Rémi Rosière, Karim Amighi, Véronique Mathieu, Florence Lefranc, Stefaan van Gool & Steven de Vleeschouwer. (2013) Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?. Cancers 5:4, pages 1020-1048.
Crossref
Crossref
Giovanni Li Volti, Teresa Musumeci, Rosario Pignatello, Paolo Murabito, Ignazio Barbagallo, Claudia Carbone, Antonino Gullo & Giovanni Puglisi. (2012) Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Experimental Biology and Medicine 237:6, pages 670-677.
Crossref
Crossref